» Articles » PMID: 1534240

Roles of Alpha Beta and Gamma Delta T Cell Subsets in Viral Immunity

Overview
Date 1992 Jan 1
PMID 1534240
Citations 122
Authors
Affiliations
Soon will be listed here.
Abstract

The current status of T-cell subset involvement in viral immunity is summarized for experimental studies in mice. The immunobiology of the normal host response is discussed, with particular reference to lymphocytic choriomeningitis (LCM) and influenza. The general impression is that CD8+ cytotoxic T lymphocytes, CD4+ TH1 cells, gamma interferon, and IL-2 are of major importance, with these different components of the immune system interacting to promote an optimal response. However, experiments with a variety of virus systems indicate that there is considerable plasticity, at least in young, adult mice. Other mechanisms often compensate if a key lymphocyte subset is absent throughout the development of the immune response. Influenza-infected mice depleted of either CD4+ or CD8+ T cells clear virus and recover, though the latter may not be true for the elimination of LCM virus. Emerging information on the involvement of gamma delta T cells in viral pneumonia is summarized, but there is as yet no understanding of the biological significance (if any) of these lymphocytes in viral immunity. The point is made that alpha beta T-cell memory to viruses is long-lived, and the need for antigen persistence to maintain such memory is questioned.

Citing Articles

A Multi-epitope Vaccine Candidate Against Bolivian Hemorrhagic fever Caused by Machupo Virus.

Ali Z, Cardoza J, Basak S, Narsaria U, Bhattacharjee S, G U Appl Biochem Biotechnol. 2023; 196(4):2137-2160.

PMID: 37479961 DOI: 10.1007/s12010-023-04604-9.


In silico design of a multi-epitope vaccine against HPV16/18.

Sanami S, Rafieian-Kopaei M, Ashrafi Dehkordi K, Pazoki-Toroudi H, Azadegan-Dehkordi F, Mobini G BMC Bioinformatics. 2022; 23(1):311.

PMID: 35918631 PMC: 9344258. DOI: 10.1186/s12859-022-04784-x.


Immunoinformatics Approach Toward the Introduction of a Novel Multi-Epitope Vaccine Against .

Tan C, Zhu F, Xiao Y, Wu Y, Meng X, Liu S Front Immunol. 2022; 13:887061.

PMID: 35720363 PMC: 9204425. DOI: 10.3389/fimmu.2022.887061.


Designing a novel multi‑epitope vaccine against Ebola virus using reverse vaccinology approach.

Alizadeh M, Amini-Khoei H, Tahmasebian S, Ghatrehsamani M, Samani K, Edalatpanah Y Sci Rep. 2022; 12(1):7757.

PMID: 35545650 PMC: 9094136. DOI: 10.1038/s41598-022-11851-z.


In silico designing of vaccine candidate against Clostridium difficile.

Basak S, Deb D, Narsaria U, Kar T, Castiglione F, Sanyal I Sci Rep. 2021; 11(1):14215.

PMID: 34244557 PMC: 8271013. DOI: 10.1038/s41598-021-93305-6.